276 related articles for article (PubMed ID: 26105139)
1. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
2. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
3. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
Yohn SE; Thompson C; Randall PA; Lee CA; Müller CE; Baqi Y; Correa M; Salamone JD
Psychopharmacology (Berl); 2015 Apr; 232(7):1313-23. PubMed ID: 25323625
[TBL] [Abstract][Full Text] [Related]
4. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
5. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.
Yohn SE; Alberati D; Correa M; Salamone JD
Psychopharmacology (Berl); 2017 May; 234(9-10):1525-1534. PubMed ID: 28083675
[TBL] [Abstract][Full Text] [Related]
7. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
[TBL] [Abstract][Full Text] [Related]
8. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
López-Cruz L; San Miguel N; Carratalá-Ros C; Monferrer L; Salamone JD; Correa M
Neuropharmacology; 2018 Aug; 138():349-359. PubMed ID: 29408363
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040.
Yohn SE; Gogoj A; Haque A; Lopez-Cruz L; Haley A; Huxley P; Baskin P; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Sep; 148():84-91. PubMed ID: 27296079
[No Abstract] [Full Text] [Related]
10. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
11. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
[TBL] [Abstract][Full Text] [Related]
12. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
[TBL] [Abstract][Full Text] [Related]
13. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
14. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
15. Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.
Yohn SE; Gorka D; Mistry A; Collins S; Qian E; Correa M; Manchanda A; Bogner RH; Salamone JD
J Nat Prod; 2017 Oct; 80(10):2839-2844. PubMed ID: 28905625
[TBL] [Abstract][Full Text] [Related]
16. Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles.
Carratalá-Ros C; Martínez-Verdú A; Olivares-García R; Salamone JD; Correa M
Psychopharmacology (Berl); 2023 Aug; 240(8):1615-1628. PubMed ID: 37407727
[TBL] [Abstract][Full Text] [Related]
17. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
Podurgiel SJ; Yohn SE; Dortche K; Correa M; Salamone JD
Behav Brain Res; 2016 Feb; 298(Pt B):188-91. PubMed ID: 26590367
[TBL] [Abstract][Full Text] [Related]
18. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811
[TBL] [Abstract][Full Text] [Related]
19. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
